These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30893264)

  • 1. Macrophages participate in the immunosuppression of condyloma acuminatum through the PD-1/PD-L1 signaling pathway.
    Liao LC; Hu B; Zhang SP
    J Chin Med Assoc; 2019 May; 82(5):413-418. PubMed ID: 30893264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and significance of PD-L1 in condyloma acuminatum.
    Liu Y; Huang W; Yang K; Du X; Guo X; Cao Y
    Skin Res Technol; 2024 Jan; 30(1):e13558. PubMed ID: 38186053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling.
    Zong Z; Zou J; Mao R; Ma C; Li N; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Front Immunol; 2019; 10():1643. PubMed ID: 31379842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible regulatory effect of the PD-1/PD-L1 signaling pathway on Tregs in ovarian cancer.
    Chen JX; Yi XJ; Gao SX; Sun JX
    Gen Physiol Biophys; 2020 Jul; 39(4):319-330. PubMed ID: 32902402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children.
    Xi X; Liu JM; Guo JY
    Int Arch Allergy Immunol; 2018; 176(3-4):255-267. PubMed ID: 29874664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of PD-1/PD-L1 in microenvironment of breast cancer].
    Ji P; Gong Y; Hu X
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):401-405. PubMed ID: 31216823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in research on tumor immune PD-1/PD-L1 signaling pathway in malignant bone tumors].
    Huang HF; Zhu H; Yang XT; Guo XY; Li SS; Xie Q; Tian XB; Yang Z
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):410-414. PubMed ID: 31216825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.
    Cai H; Zhang Y; Wang J; Gu J
    Front Immunol; 2021; 12():690869. PubMed ID: 34248982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
    Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
    J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 Deficiency Promotes Macrophage Activation and T-Helper Cell Type 1/T-Helper Cell Type 17 Response in
    Zhang C; Rong HM; Li T; Zhai K; Tong ZH
    Am J Respir Cell Mol Biol; 2020 Jun; 62(6):767-782. PubMed ID: 32048861
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of condyloma acuminatum.
    Lee WL; Lee FK; Wang PH
    J Chin Med Assoc; 2019 Aug; 82(8):605-606. PubMed ID: 31135577
    [No Abstract]   [Full Text] [Related]  

  • 15. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic investigation of immunosuppression in patients with condyloma acuminata.
    Shi YJ; Yang J; Yang W
    Mol Med Rep; 2013 Aug; 8(2):480-6. PubMed ID: 23754510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.
    Hartley GP; Chow L; Ammons DT; Wheat WH; Dow SW
    Cancer Immunol Res; 2018 Oct; 6(10):1260-1273. PubMed ID: 30012633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L1 inhibition promotes hepatic regeneration in small-for-size liver following extended hepatectomy.
    Yan X; Shi JH; Xue JF; Guo WZ; Li B; Zhang SJ
    Cytokine; 2022 Nov; 159():156017. PubMed ID: 36054963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
    Che YM; Zhang Y; Li M; Li XP; Zhang LL
    J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.